Stockscreener 앱 받기
15.06
1.70%
-0.26
전일 마감가:
$15.32
열려 있는:
$15.15
하루 거래량:
679.10K
Relative Volume:
0.85
시가총액:
$1.59B
수익:
-
순이익/손실:
$-150.70M
주가수익비율:
-9.7161
EPS:
-1.55
순현금흐름:
$-125.67M
1주 성능:
-0.33%
1개월 성능:
+8.42%
6개월 성능:
+11.97%
1년 성능:
-57.59%
1일 변동 폭
$14.88
$15.39
1주일 범위
$14.25
$16.60
52주 변동 폭
$10.60
$38.12
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
EWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
15.06 | 1.61B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-25 | 개시 | Goldman | Neutral |
| 2025-07-30 | 개시 | Raymond James | Strong Buy |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-04-30 | 개시 | Guggenheim | Buy |
| 2025-04-02 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-22 | 개시 | Stifel | Hold |
| 2024-11-22 | 개시 | Evercore ISI | Outperform |
| 2024-03-07 | 개시 | Piper Sandler | Overweight |
| 2023-05-01 | 개시 | Truist | Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2022-01-28 | 개시 | Goldman | Neutral |
모두보기
엣지와이즈 주식(EWTX)의 최신 뉴스
What valuation multiples suggest for Edgewise Therapeutics Inc. stockTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Multi asset correlation models including Edgewise Therapeutics Inc.July 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com
Building trade automation scripts for Edgewise Therapeutics Inc.2025 Short Interest & Growth Focused Entry Point Reports - newser.com
How to build a custom watchlist for Edgewise Therapeutics Inc.Insider Buying & Accurate Entry/Exit Alerts - newser.com
Aberdeen Group plc Buys 130,294 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Price momentum metrics for Edgewise Therapeutics Inc. explainedOptions Play & Real-Time Volume Trigger Notifications - newser.com
Why Edgewise Therapeutics Inc. is moving todayWeekly Investment Summary & Low Risk Entry Point Guides - newser.com
Edgewise Therapeutics Inc. stock trend forecastJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com
Can a trend reversal in Edgewise Therapeutics Inc. lead to recoveryJuly 2025 Trends & Safe Capital Growth Tips - newser.com
What recovery options are there for Edgewise Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - newser.com
Key metrics from Edgewise Therapeutics Inc.’s quarterly data2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Is Edgewise Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
How to use a screener to detect Edgewise Therapeutics Inc. breakoutsMarket Movers & Risk Controlled Stock Alerts - newser.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Can Edgewise Therapeutics Inc. stock beat analyst upgrades2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
What analysts say about Edgewise Therapeutics Inc stockMACD Trading Signals & Fast Growing Stocks - earlytimes.in
What drives Edgewise Therapeutics Inc stock priceHigh Frequency Trading Trends & High Return Stock Ideas - earlytimes.in
Edgewise Therapeutics (EWTX): Exploring Valuation After Positive Long-Term Data on Sevasemten in Muscular Dystrophy Trials - Sahm
How high can Edgewise Therapeutics Inc. stock goJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 5.1%Here's What Happened - MarketBeat
Edgewise Therapeutics, Inc.Common Stock (Nasdaq:EWTX) Price Chart | News | postregister.com - FinancialContent
Applying Elliott Wave Theory to Edgewise Therapeutics Inc.Portfolio Return Report & Technical Entry and Exit Tips - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
How Investors May Respond To Edgewise Therapeutics (EWTX) Long-Term Sevasemten Data at World Muscle Congress - Yahoo Finance
Edgewise Therapeutics (EWTX): Evaluating Valuation as New Long-Term Clinical Data Sparks Investor Interest - Yahoo Finance
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring A 135.53% Upside Potential - DirectorsTalk Interviews
How Investors Are Reacting To Edgewise Therapeutics (EWTX) Unveiling Long-Term Data for Sevasemten at WMS 2025 - Sahm
Edgewise Therapeutics presents muscular dystrophy research at Vienna conference - Traders Union
Tools to monitor Edgewise Therapeutics Inc. recovery probabilityWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress
Edgewise Therapeutics (EWTX): Reviewing Valuation After Recent Momentum Shifts - Sahm
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by HighMark Wealth Management LLC - MarketBeat
Best data tools to analyze Edgewise Therapeutics Inc. stockTrade Entry Report & Smart Money Movement Tracker - newser.com
Will earnings trigger a reversal in Edgewise Therapeutics Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Edgewise Therapeutics reports inducement grants as permitted by Nasdaq listing rules - MarketScreener
Breakthrough Muscular Dystrophy Treatment: Edgewise's Sevasemten Shows Disease Stabilization in Key Trials - Stock Titan
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet - MSN
Is Edgewise Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Set Up Real-Time Alerts – It’s Free - earlytimes.in
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):